Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$779K Hold
32,337
0.41% 38
2026
Q1
$908K Hold
32,337
0.54% 37
2025
Q4
$805K Sell
32,337
-42,200
-57% -$1.06M 0.37% 38
2025
Q3
$1.9M Hold
74,537
0.77% 22
2025
Q2
$1.81M Sell
74,537
-180,000
-71% -$4.2M 0.82% 22
2025
Q1
$6.45M Hold
254,537
3.04% 6
2024
Q4
$6.75M Buy
254,537
+30,000
+13% +$814K 2.44% 8
2024
Q3
$6.5M Sell
224,537
-24,200
-10% -$706K 2.28% 8
2024
Q2
$6.96M Buy
248,737
+1,200
+0.5% +$33K 2.78% 7
2024
Q1
$6.87M Buy
247,537
+150,000
+154% +$4.16M 2.43% 10
2023
Q4
$2.81M Hold
97,537
1.07% 16
2023
Q3
$3.23M Hold
97,537
1.24% 13
2023
Q2
$3.58M Hold
97,537
1.42% 14
2023
Q1
$3.98M Buy
97,537
+3,037
+3% +$131K 1.56% 14
2022
Q4
$4.84M Sell
94,500
-49,000
-34% -$2.35M 1.83% 12
2022
Q3
$6.28M Hold
143,500
2.64% 8
2022
Q2
$7.52M Hold
143,500
3.16% 8
2022
Q1
$7.43M Buy
143,500
+39,000
+37% +$2.02M 2.37% 8
2021
Q4
$6.17M Buy
+104,500
New +$5.18M 2.09% 10

Other funds holding PFE

David M. Knott Jr's PFE Position: Q2 2026 in Review

David M. Knott Jr held its Pfizer (PFE) position steady in Q2 2026 at 32,337 shares worth $779K. The position accounts for 0.41% of the portfolio, ranked #38.

David M. Knott Jr first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.52M in Q2 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • David M. Knott Jr held 32,337 shares of Pfizer worth $779K as of Q2 2026.
  • David M. Knott Jr left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.41% of David M. Knott Jr's portfolio in Q2 2026, its #38 holding.
  • David M. Knott Jr first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • David M. Knott Jr's Pfizer position peaked at $7.52M in Q2 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.